Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Chen, Yu-An, Lin, Ying-Ju, Lin, Cheng-Li, Lin, Hwai-Jeng, Wu, Hua-Shan, Hsu, Hui-Ying, Sun, Yu-Chen, Wu, Hui-Yu, Lai, Chih-Ho, Kao, Chia-Hung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874326/
https://ncbi.nlm.nih.gov/pubmed/29623039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00225
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller